Detailed Narrative
Strong Q4 & FY26 Financial Performance
GPT Healthcare reported a robust Q4 FY26 with revenue from operations growing 24% year-on-year to INR 128 crores, achieving an EBITDA of INR 25 crores and a PAT of INR 14.7 crores. For the full fiscal year 2026, revenue stood at INR 478.5 crores, with an EBITDA of INR 90.1 crores and PAT of INR 42.2 crores. Notably, the EBITDA margin, excluding the newly commissioned Raipur Hospital, improved by 94 basis points to 23.06% compared to 22.1% in FY25, demonstrating strong performance from mature assets.
Operational Momentum Across Mature Hospitals
Mature hospitals showed consistent operational improvements. Salt Lake Hospital saw its occupancy rise from 58% to 63% in FY26, with Q4 ARPOB reaching INR 43,800. ILS Dumdum achieved a 71% occupancy in Q4 FY26 following strategic restructuring and the introduction of cardiac surgery programs. ILS Agartala's occupancy improved from 42% to 52% in Q4 FY26, contributing to an almost 18% growth in the hospital's performance. ILS Howrah also saw its occupancy increase from 39% to 47% in Q4 FY26, supported by new robotic knee replacement surgeries.
Raipur Hospital's Strategic Ramp-up and Challenges
The Raipur Hospital, commissioned in May 2025, recorded an occupancy of 12.35% for FY26 and 14.26% for Q4 FY26, contributing a negative EBITDA of INR 13.8 crores for the fiscal year. Management expects Raipur to reach monthly breakeven by Q3 FY27 and achieve 30% occupancy by the end of FY27. The slower-than-anticipated ramp-up is primarily attributed to delays in insurance empanelment, which is expected to be completed in Q1 FY27, after which a significant improvement in performance is anticipated.
Expansion & Capital Allocation Strategy
The Jamshedpur 150-bed tertiary care hospital project is progressing as planned, with commissioning expected by Q4 FY27. The capex per bed for Jamshedpur is estimated at INR 70 lakhs, similar to Raipur, with 90% of GPT's capex for this project to be deployed in FY27. The company is actively evaluating both greenfield and acquisition opportunities in the underserved Eastern markets, with a preference for hospitals in the 150-200 bed range, aiming to achieve a long-term vision of a 1,000-bed hospital chain.
Market Dynamics and Payer Mix
India's healthcare sector continues to benefit from structural tailwinds like rising awareness, increasing chronic diseases, and growing insurance penetration. GPT Healthcare maintains a strong payer mix, with approximately 90% of its revenues derived from cash and insurance patients, split roughly 50-50. Corporate and scheme patients (including Ayushman Bharat) contribute about 10%. The transition to Ayushman Bharat in West Bengal is viewed as a welcome move, with no significant impact expected on ARPOB.
Specialty Focus and Clinical Excellence
The company continues to strengthen its tertiary care capabilities across its network. Salt Lake is a flagship robotic surgery center, while Dumdum has commenced cardiac surgeries and enhanced interventional capabilities. Agartala has expanded oncology care and received approvals for renal transplants. Howrah has introduced robotic knee replacement surgeries. Raipur is also focusing on oncology, GI surgery, and renal sciences. This focus on advanced tertiary care and technology-led delivery is a key differentiator and marketing medium.